Join
Live feed
·
PRReleasevia Quantisnow
CVRx Inc. logo

CVRx Announces Initiation of BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population

ByQuantisnow·Wall Street's wire, on your screen.
CVRX· CVRx Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CVRX (CVRx Inc.) and more on Quantisnow.